{"id":"NCT00696423","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children","officialTitle":"Immunogenicity and Reactogenicity Study of GlaxoSmithKline Biologicals' Infanrix™/Hib Vaccine Administered as a Booster Dose to 18-24 Months Old Children","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06-07","primaryCompletion":"2008-07-26","completion":"2008-07-26","firstPosted":"2008-06-12","resultsPosted":"2009-08-26","lastUpdate":"2018-06-06"},"enrollment":467,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Acellular Pertussis","Diphtheria","Tetanus"],"interventions":[{"type":"BIOLOGICAL","name":"Infanrix™","otherNames":[]},{"type":"BIOLOGICAL","name":"Hiberix™","otherNames":[]}],"arms":[{"label":"Infanrix/Hib Single Injection Group","type":"EXPERIMENTAL"},{"label":"Infanrix + Hiberix Separate Injection Group","type":"ACTIVE_COMPARATOR"}],"summary":"This protocol posting deals with objectives \\& outcome measures of the booster phase. The objectives \\& outcome measures of the primary phase are presented in a separate protocol posting (NCT number = NCT00412854). This Phase IIIB study will compare GSK Biologicals' DTPa/Hib vaccine to separately administered DTPa and Hib vaccines in Chinese children 18 to 24 months of age, in terms of safety and immunogenicity.","primaryOutcome":{"measure":"Anti-polyribosyl-ribitol-phosphate (PRP) Antibody Concentrations","timeFrame":"One month after booster vaccination","effectByArm":[{"arm":"Infanrix/Hib Single Injection Group","deltaMin":34.428,"sd":null},{"arm":"Infanrix + Hiberix Separate Injection Group","deltaMin":132.075,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":3,"countries":["China"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Fever","Irritability","Loss of appetite","Nasopharyngitis","Pain at injection site"]}}